BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lino-Silva LS, Gamboa-Domínguez A, Zúñiga-Tamayo D, Salcedo-Hernández RA, Cetina L, Cantú-de-León D. Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study. World J Clin Oncol 2018; 9(7): 133-139 [PMID: 30425938 DOI: 10.5306/wjco.v9.i7.133]
URL: https://www.wjgnet.com/2218-4333/full/v9/i7/133.htm
Number Citing Articles
1
Sara Cherri, Ester Oneda, Silvia Noventa, Laura Melocchi, Alberto Zaniboni. Microsatellite instability and chemosensitivity in solid tumoursTherapeutic Advances in Medical Oncology 2022; 14: 175883592210993 doi: 10.1177/17588359221099347
2
Pantea Pour Farid, Markus Eckstein, Susanne Merkel, Robert Grützmann, Arndt Hartmann, Volker Bruns, Michaela Benz, Regine Schneider-Stock, Carol I. Geppert. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological SubtypesInternational Journal of Molecular Sciences 2021; 22(23): 13108 doi: 10.3390/ijms222313108
3
E. O'Connell, I.S. Reynolds, D.A. McNamara, J.H.M. Prehn, J.P. Burke. Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysisSurgical Oncology 2020; 34: 57 doi: 10.1016/j.suronc.2020.03.009
4
Alessandro Lugli, Inti Zlobec, Martin D. Berger, Richard Kirsch, Iris D. Nagtegaal. Tumour budding in solid cancersNature Reviews Clinical Oncology 2021; 18(2): 101 doi: 10.1038/s41571-020-0422-y
5
Sonay Kus Öztürk, Tariq S. Haddad, Inti Zlobec, Alessandro Lugli, Iris D. Nagtegaal. Attackers and defenders: tumor buds and lymphocytes as morphological biomarkers in colorectal cancerDiagnostic Histopathology 2022; 28(11): 480 doi: 10.1016/j.mpdhp.2022.08.002
6
Inti Zlobec, Martin D. Berger, Alessandro Lugli. Tumour budding and its clinical implications in gastrointestinal cancersBritish Journal of Cancer 2020; 123(5): 700 doi: 10.1038/s41416-020-0954-z
7
Yuho Ono, Justin M.M. Cates, Raul S. Gonzalez. Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?Pathology - Research and Practice 2021; 226: 153608 doi: 10.1016/j.prp.2021.153608
8
Felix Müller, Alessandro Lugli, Heather Dawson. Tumor Budding beim kolorektalen Karzinom – Informationen zur klinischen Anwendung und Anleitung zur praktischen BestimmungDer Pathologe 2022; 43(1): 45 doi: 10.1007/s00292-021-01016-6
9
Serena Ammendola, Nicolò Caldonazzi, Paola Chiara Rizzo, Giulia Turri, Corrado Pedrazzani, Valeria Barresi. H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal CarcinomaBiomedicines 2022; 10(8): 2042 doi: 10.3390/biomedicines10082042
10
Shehara Mendis, Yat Hang To, Jeanne Tie. Biomarkers in Locally Advanced Rectal Cancer: A ReviewClinical Colorectal Cancer 2022; 21(1): 36 doi: 10.1016/j.clcc.2021.11.002
11
Hui Jiang, Yelin Yang, Yuping Qian, Chengwei Shao, Jianping Lu, Yun Bian, Jianming Zheng. Tumor Budding Score Is a Strong and Independent Prognostic Factor in Patients With Pancreatic Ductal Adenocarcinoma: An Evaluation of Whole Slide Pathology Images of Large SectionsFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.740212
12
Annika Blank, Carla Schenker, Heather Dawson, Guido Beldi, Inti Zlobec, Alessandro Lugli. Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin StainingFrontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00247